Spasmodic Torticollis (Cervical Dystonia) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Spasmodic Torticollis (Cervical Dystonia) – Drugs In Development, 2024 report and make more profitable business decisions.
Cervical dystonia, also known as spasmodic torticollis, is a rare neurological disorder that originates in the brain. It is the most common form of focal dystonia in an office setting. Cervical dystonia is characterized by involuntary muscle contractions in the neck that cause abnormal movements and postures of the neck and head
The Spasmodic Torticollis (Cervical Dystonia) drugs in development market research report provide comprehensive information on the therapeutics under development for Spasmodic Torticollis (Cervical Dystonia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Spasmodic Torticollis (Cervical Dystonia) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Spasmodic Torticollis (Cervical Dystonia) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 7 molecules, with 7 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Spasmodic Torticollis (Cervical Dystonia) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Spasmodic Torticollis (Cervical Dystonia) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Spasmodic Torticollis (Cervical Dystonia) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Addex Therapeutics LtdAEON Biopharma Inc
Daewoong Pharmaceutical Co Ltd
Microgen
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Shionogi & Co Ltd
Viatris Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Spasmodic Torticollis (Cervical Dystonia) reports